Genomic effects of phytochemicals and their implication in the maintenance of health.

A. Scalbert & S. Knasmüller ES1–ES2

Use of conventional and -omics based methods for health claims of dietary antioxidants: a critical overview.

S. Knasmüller, A. Nersesyan, M. Mišík, C. Gerner, W. Mikulits, V. Ehrlich, C. Hoelzl, A. Szakmary & K.-H. Wagner ES3–ES52

Flavonoids and intestinal cancers.

R. Pierini, J. M. Gee, N. J. Belshaw & I. T. Johnson ES53–ES59

Flavonoids: modulators of brain function?

J. P. E. Spencer ES60–ES77

Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics.

C. Steiner, S. Arnould, A. Scalbert & C. Manach ES78–ES108

Antioxidant phytochemicals against type 2 diabetes.

A. Dembinska-Kiec, O. Mykkänen, B. Kiec-Wilk & H. Mykkänen ES109–ES117

Biological models for phytochemical research: from cell to human organism.

A. Mortensen, I. K. Sorensen, C. Wilde, S. Dragoni, D. Mullerová, O. Toussaint, Z. Zloch, G. Sgaragli & J. Ovesná ES118–ES126

High throughput ‘omics’ approaches to assess the effects of phytochemicals in human health studies.

J. Ovesná, O. Slabý, O. Toussaint, M. Kodíček, P. Maršík, V. Pouchová & T. Vaněk ES127–ES134